Literature DB >> 20202753

Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database.

Robert H Dworkin1, Dennis C Turk, Sarah Peirce-Sandner, Michael P McDermott, John T Farrar, Sharon Hertz, Nathaniel P Katz, Srinivasa N Raja, Bob A Rappaport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20202753     DOI： 10.1016/j.pain.2010.02.002

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  9 in total

1.  Assay sensitivity and study features in neuropathic pain trials: an ACTTION meta-analysis.

Authors:  Robert H Dworkin; Dennis C Turk; Sarah Peirce-Sandner; Hua He; Michael P McDermott; John T Farrar; Nathaniel P Katz; Allison H Lin; Bob A Rappaport; Michael C Rowbotham
Journal:  Neurology       Date:  2013-05-22       Impact factor: 9.910

Review 2.  Lessons learned from placebo groups in antidepressant trials.

Authors:  Meike Shedden Mora; Yvonne Nestoriuc; Winfried Rief
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

Review 3.  An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis.

Authors:  Akio Arakawa; Masayuki Kaneko; Mamoru Narukawa
Journal:  Clin Drug Investig       Date:  2015-02       Impact factor: 2.859

4.  Advances in clinical research methodology for pain clinical trials.

Authors:  John T Farrar
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

Review 5.  Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

Authors:  N Percie du Sert; A S C Rice
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

6.  Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.

Authors:  Setsuro Ogawa; Akio Arakawa; Kazuhiro Hayakawa; Tamotsu Yoshiyama
Journal:  Clin Drug Investig       Date:  2016-11       Impact factor: 2.859

7.  A Phase IIIb, Multicentre, Randomised, Parallel-Group, Placebo-Controlled, Double-Blind Study to Investigate the Efficacy and Safety of OROS Hydromorphone in Subjects with Moderate-to-Severe Chronic Pain Induced by Osteoarthritis of the Hip or the Knee.

Authors:  Jozef Vojtaššák; Jozef Vojtaššák; Adam Jacobs; Leonie Rynn; Sandra Waechter; Ute Richarz
Journal:  Pain Res Treat       Date:  2011-06-22

8.  Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials.

Authors:  Roy Freeman; Birol Emir; Bruce Parsons
Journal:  J Pain Res       Date:  2015-06-01       Impact factor: 3.133

9.  Designing and conducting proof-of-concept chronic pain analgesic clinical trials.

Authors:  Claudia M Campbell; Ian Gilron; Tina Doshi; Srinivasa Raja
Journal:  Pain Rep       Date:  2019-02-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.